Brief: Axcella Therapeutics Reports Qtrly Loss Per Share $0.41
10/11/2021 13:30
Nov 10 (Reuters) - Axcella Health Inc AXLA.O :
* AXCELLA THERAPEUTICS REPORTS THIRD QUARTER FINANCIAL
RESULTS AND
PROVIDES UPDATE ON LONG COVID, OHE AND NASH CLINICAL TRIALS
* AXCELLA HEALTH INC - QTRLY LOSS PER SHARE $0.41
* AXCELLA HEALTH - CONTINUES TO EXPECT EXISTING CASH BALANCE
TO BE
SUFFICIENT TO MEET CO'S OPERATING NEEDS INTO Q3 2022
Source text for Eikon: ID:nBw3BHP5Ga
Further company coverage: AXLA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Axcella Health
See all newsAxcella Health Inc expected to post a loss of $1.25 a share - Earnings Preview
Brief: Axcella Health Inc- On Oct 4, Co Received Notice From Nasdaq That Co Had Regained Compliance With Nasdaq
Brief: Axcella Announces Reverse Stock Split Effective September 19, 2023
U.S. STOCKS ON THE MOVE-PDD Holdings, Catalent, Best Buy
Brief: Axcella Granted Patent For Long Covid Fatigue Treatment